Massachusetts Financial Services’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,295
| Closed | -$257K | – | 859 |
|
|
2020
Q1 | $257K | Buy |
2,295
+363
| +19% | +$40.7K | ﹤0.01% | 785 |
|
|
2019
Q4 | $473K | Sell |
1,932
-208
| -10% | -$50.9K | ﹤0.01% | 783 |
|
|
2019
Q3 | $737K | Buy |
2,140
+242
| +13% | +$83.3K | ﹤0.01% | 785 |
|
|
2019
Q2 | $1.75M | Buy |
1,898
+1,093
| +136% | +$1.01M | ﹤0.01% | 747 |
|
|
2019
Q1 | $1.28M | Buy |
805
+30
| +4% | +$47.9K | ﹤0.01% | 766 |
|
|
2018
Q4 | $1.45M | Buy |
775
+60
| +8% | +$112K | ﹤0.01% | 739 |
|
|
2018
Q3 | $1.69M | Buy |
715
+240
| +51% | +$566K | ﹤0.01% | 734 |
|
|
2018
Q2 | $1.64M | Buy |
475
+65
| +16% | +$224K | ﹤0.01% | 727 |
|
|
2018
Q1 | $1.16M | Buy |
410
+6
| +1% | +$17K | ﹤0.01% | 743 |
|
|
2017
Q4 | $1.04M | Buy |
404
+57
| +16% | +$147K | ﹤0.01% | 761 |
|
|
2017
Q3 | $985K | Sell |
347
-5
| -1% | -$14.2K | ﹤0.01% | 749 |
|
|
2017
Q2 | $832K | Buy |
352
+10
| +3% | +$23.6K | ﹤0.01% | 776 |
|
|
2017
Q1 | $862K | Buy |
342
+4
| +1% | +$10.1K | ﹤0.01% | 763 |
|
|
2016
Q4 | $762K | Buy |
338
+110
| +48% | +$248K | ﹤0.01% | 787 |
|
|
2016
Q3 | $571K | Buy |
228
+53
| +30% | +$133K | ﹤0.01% | 804 |
|
|
2016
Q2 | $535K | Buy |
175
+28
| +19% | +$85.6K | ﹤0.01% | 781 |
|
|
2016
Q1 | $467K | Sell |
147
-6
| -4% | -$19.1K | ﹤0.01% | 785 |
|
|
2015
Q4 | $785K | Buy |
+153
| New | +$785K | ﹤0.01% | 747 |
|
|
2013
Q3 | – | Sell |
-59
| Closed | -$234K | – | 850 |
|
|
2013
Q2 | $234K | Buy |
+59
| New | +$234K | ﹤0.01% | 798 |
|